[NEJM] Talquetamab–Daratumumab in Relapsed or Refractory Myeloma

 关闭 求助已关闭
zhanghao 发表于 3 天前 | 显示全部楼层 |阅读模式
悬赏10积分

期刊:New England Journal of Medicine

文献作者:Roberto Mina; Meral Beksac; Paula Rodríguez-Otero; Wenming Chen; María-Victoria Mateos; Jian Li; Philippe Moreau; Yael C. Cohen; Chang-Ki Min; Tomas Jelinek; Jing Christine Ye; Hila Magen; Samuel M. Rubinstein; Weijun Fu; Vania Hungria; Guldane Cengiz Seval; Joao Samuel Farias; Jakub Radocha; Senem Maral; Mehmet Turgut; Youngil Koh; Daniel O’Leary; Jayr Schmidt Filho; Raymond Thertulien; Gang An; Shang-Yi Huang; Sebastian Grosicki; Agata Tyczyńska; Rahul Banerjee; Matthew J. Pianko; Joaquín Martínez-López; Pawel Steckiewicz; Dai Maruyama; Kentaro Fukushima; Albert Oriol; Jordi Lopez Pardo; Hartmut Goldschmidt; Charlotte Pawlyn; Aurore Perrot; Elena Zamagni; Meletios A. Dimopoulos; Leo Rasche; Jaszianne Tolbert; William Terry; Christelle Courtoux; Xiao Liu; Sandra Y. Vasey; Kaitlyn Connors; Mariacristina Festa; Christoph Heuck; Angélique Langlois; Lisa O’Rourke; Jiangxiu Zhou; Xiang Qin; Jiashen Lu; Joy Gong; Diego Vieyra; Peter M. Voorhees

出版日期:2026-8-13

DOI号:10.1056/nejmoa2604657

下载链接:http://www.nejm.org/doi/pdf/10.1056/NEJMoa2604657

文献链接:https://doi.org/10.1056/nejmoa2604657

当前文献来源于 Massachusetts Medical Society


备注信息:

已采纳

附件内容

查看完整内容

全部回复1 显示全部楼层
woshi123 发表于 3 天前 | 显示全部楼层

当前求助已完成,请重新发起求助。

已完结状态的附件将会在24小时内删除。
返回列表